|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1999-5-28
|
|
pubmed:abstractText |
Treatment with angiotensin-converting enzyme (ACE) inhibitors in congestive heart failure (CHF) improves cardiac and peripheral hemodynamic function and exercise performance. However, studies on the effects of long-term treatment with an ACE inhibitor on the neurogenic and nonneurogenic regulation and structural microangiopathy of the peripheral microvasculature in CHF are lacking.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1071-9164
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
17-24
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10194656-Aged,
pubmed-meshheading:10194656-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:10194656-Female,
pubmed-meshheading:10194656-Fosinopril,
pubmed-meshheading:10194656-Heart Failure,
pubmed-meshheading:10194656-Humans,
pubmed-meshheading:10194656-Male,
pubmed-meshheading:10194656-Microcirculation,
pubmed-meshheading:10194656-Middle Aged,
pubmed-meshheading:10194656-Muscle, Skeletal,
pubmed-meshheading:10194656-Pressoreceptors,
pubmed-meshheading:10194656-Regional Blood Flow,
pubmed-meshheading:10194656-Time Factors,
pubmed-meshheading:10194656-Vascular Resistance
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Reversal of peripheral microvascular dysfunction during long-term treatment with the angiotensin-converting enzyme inhibitor fosinopril in congestive heart failure.
|
|
pubmed:affiliation |
Heart Center, Rigshospital, University of Copenhagen, Denmark.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
